title: [Carcinoma of the uterine cervix during pregnancy].
abstract: Pregnancy offers a unique opportunity for the early diagnosis of cervical cancer, due to the fact that pregnant patients have many possibilities of gynecological and cytological examinations. There is much evidence that pregnant women have two to three-fold higher chance of having preneoplastic lesions and early, operable stages of disease diagnosed. The preneoplastic lesions do not require any intervention during pregnancy. However, precise, serial colposcopic examinations, completed by biopsy if necessary, must be seriously considered in order to exclude invasive cancer. The only indication for conization during pregnancy is to rule out or confirm microinvasive or invasive cancer, provided such diagnose can change the time and the way of delivery. Invasive cervical cancer diagnose is frequently associated with difficult medical and ethical decisions. The most proper approach should be considered, taking into account the benefit of the mother and the child. The decision is easier in the early stage of cancer, because it has been proven that six- to twelve-week delay of the beginning of the therapy does not deteriorate the cancer outcome but it enables the fetus to acquire sufficient lung maturity. Advanced carcinoma of the cervix forces us to take prompt therapeutic decisions. Both, the continuation of the pregnancy and the administration of neoadjuvant chemotherapy are still possible.
authors.affiliation: Klinika Onkologii Ginekologicznej Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. ewamarkwitz@poczta.fm
authors.forename: Ewa
authors.initials: E
authors.lastname: Nowak-Markwitz
authors.forename: Marek
authors.initials: M
authors.lastname: Spaczyński
mesh_terms: D002584:Cervix Uteri / Q000473:pathology; D003127:Colposcopy / Q000379:methods; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000473:pathology* / Q000628:therapy*; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000628:therapy*; D016387:Women's Health; D002578:Uterine Cervical Dysplasia / Q000473:pathology* / Q000628:therapy*